Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$472.35 USD

472.35
432,975

+3.17 (0.68%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 249)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

IDEXX Laboratories (IDXX) Beats on Q2 Earnings and Revenues

IDEXX Laboratories (IDXX) gains on solid contributions from Companion Animal Group business in Q2.

    Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates

    Idexx (IDXX) delivered earnings and revenue surprises of 4.24% and 1.01%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

      Can CAG Growth Continue to Aid IDEXX (IDXX) in Q2 Earnings?

      IDEXX (IDXX) is enhancing its commercial capabilities in the United States to maintain recurring revenue growth at CAG Diagnostics.

        Should You Invest in the First Trust Water ETF (FIW)?

        Sector ETF report for FIW

          MASI or STE: Which Is a Better Investment Option Right Now?

          Masimo's (MASI) and STERIS' (STE) strong expected growth rates and impressive price performance make them close contenders in the Medical Instruments space.

            Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks

            The suspension of the Medical Device Tax, the evolution of mechatronics and big data in the MedTech space make some of the stocks lucrative picks for investment.

              IDEXX Laboratories Global Growth Solid on Catalyst Uptake

              IDEXX (IDXX) steadily demonstrates strong organic growth, driven by solid sales at the Companion Animal Group (CAG) business, fueled by a firm global Catalyst uptake.

                Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

                Is IDEXX Laboratories, Inc. (IDXX) Outperforming Other Medical Stocks This Year?

                  BSX or BAX: Which is a Better Pick for Your Portfolio Now?

                  After considering various parameters and fundamentals, we help you make a choice between Boston Scientific (BSX) and Baxter (BAX).

                    Should You Invest in the First Trust Water ETF (FIW)?

                    Sector ETF report for FIW

                      Why You Should Add IDEXX (IDXX) Stock to Your Portfolio?

                      IDEXX's (IDXX) stellar performance is primarily driven by robust sales at the CAG (Companion Animal Group) business.

                        IDEXX Laboratories (IDXX) Up 6.4% Since Earnings Report: Can It Continue?

                        IDEXX Laboratories (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                          Time to Focus on IDEXX Laboratories (IDXX) for Strong Earnings Growth Potential

                          IDEXX Laboratories (IDXX) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

                            IDEXX's (IDXX) Catalyst Uptake Remains Strong & Boosts CAG

                            Solid organic growth trend within IDEXX's (IDXX) CAG revenues to sustain on the back of a strong global placement of high-premium Catalyst instruments.

                              Should You Invest in the First Trust Water ETF (FIW)?

                              Sector ETF report for FIW

                                IDEXX (IDXX) Hits a 52-Week High, Can the Run Continue?

                                IDEXX Laboratories, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for IDXX for clues.

                                  IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1

                                  IDEXX (IDXX) rides on strength in CAG business in Q1. A raised EPS guidance buoys optimism.

                                    Zacks.com highlights: Louisiana-Pacific, IDEXX Laboratories, SolarEdge Technologies, Curtiss-Wright and Autohome

                                    Zacks.com highlights: Louisiana-Pacific, IDEXX Laboratories, SolarEdge Technologies, Curtiss-Wright and Autohome

                                      IDEXX Laboratories (IDXX) Beats on Q1 Revenues, View Upbeat

                                      IDEXX Laboratories (IDXX) gains on solid contributions from Companion Animal Group business in Q1.

                                        Invest in These 5 Low Leverage Stocks to Earn Steady Returns

                                        With the Q1 earnings season in full swing right now, investors should target low-leveraged stocks exhibiting solid earnings growth.

                                          Can CAG Growth for IDEXX (IDXX) Stock Return in Q1 Earnings?

                                          IDEXX (IDXX) might repeat its gain streak in CAG for Q1, earlier driven by strong double-digit growth in reference labs and consumables plus a high-single-digit rise in rapid assay sales.

                                            LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?

                                            LeMaitre Vascular, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for LMAT for clues.

                                              The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions

                                              The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions

                                                Tirthankar Chakraborty headshot

                                                5 Top-Performing S&P 500 Stocks of Q1

                                                We have highlighted five S&P 500 stocks that have dished out double-digit returns in Q1 and remained undisturbed by higher bouts of volatility

                                                  Why Should You Add IDEXX (IDXX) Stock to Your Portfolio?

                                                  IDEXX (IDXX) might gain from the commercial launch of Catalyst SDMA Test in North America. As a result, its point-of-care customers can add SDMA as an essential element to the routine chemistry panel.